| ²é¿´: 353 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[ÇóÖú]
É걨һ¸ö¿ÎÌ⣬ÐèÒª·ÒëÒÔÏÂÎÄ×Ö£¬½ô¼±ÇóÖú£¬SOS SOS
|
|||
|
1. ÐèҪȷ֤ÅäÎéµÄºÏÀíÐÔ 2. ҪʵÏÖҩЧÓëÒ©´úÔÚÒ»¸ö¼ÁÐÍÖеÄе÷¡£ 3. ¿ÉÄÜ·¢ÉúÒ©Îï-Ò©ÎïÏ໥×÷Óà 4. ÒªÏòÒ©Õþ²¿ÃÅÂÛÖ¤ºÏÓõĸù¾Ý£¬Ðë½øÐÐһϵÁжÔÕÕÊÔÑ飬֤Ã÷×éºÏµÄÒ©Îï¼°¼ÁÁ¿µÄºÏÀíÐÔ¡£ |
» ²ÂÄãϲ»¶
327Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
283·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Ò»Ö¾Ô¸211£¬0703»¯Ñ§305·ÖÇóµ÷¼Á
ÒѾÓÐ16È˻ظ´
»·¾³×¨Ë¶µ÷¼Á
ÒѾÓÐ13È˻ظ´
293µ÷¼Á
ÒѾÓÐ5È˻ظ´
338Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸»ªÄÏʦ·¶´óѧ0702ÎïÀíѧ305µ÷¼Á
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ30È˻ظ´

ÐÒ¸£µÄ°®¶¹
гæ (³õÈëÎÄ̳)
- ·ÒëEPI: 2
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 138.5
- Ìû×Ó: 17
- ÔÚÏß: 5.3Сʱ
- ³æºÅ: 1054500
- ×¢²á: 2010-07-09
- ÐÔ±ð: MM
- רҵ: ¹ú¼Ê·¨Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
sltmac(½ð±Ò+1): 2012-02-24 09:36:46
³ÁDZºÓ½(½ð±Ò+5, ·ÒëEPI+1): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-02-24 10:59:09
³ÁDZºÓ½(½ð±Ò+5, ·ÒëEPI+1): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-02-24 10:59:09
|
1. The rationality of the compatibility should be confirmed. 2. The coordination between pharmacodynamics and pharmacokinetics in a dosage form should be realized. 3. The possible drug-drug interactions. 4. The evidence of availability should be submitted to drug administration department, which should be on the basis of a series of control experiments that prove the rationality of the combined drugs and dosage. |

2Â¥2012-02-23 22:25:52














»Ø¸´´ËÂ¥